These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 7134213)

  • 1. [Hepatotoxic action of rifampicin and isonicotinic acid hydrazide].
    Kozma D; Mihalik P; Schaff Z; Lapis K
    Probl Tuberk; 1982 Jul; (7):68-72. PubMed ID: 7134213
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative hepatic toxicity of isoniazid, rifampicin and ethambutol].
    Skakun NP; Tabachuk OE
    Probl Tuberk; 1991; (10):77-9. PubMed ID: 1788241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of the effects of the rifampin-isoniazid combination on the human liver].
    Plomteux G; Heusghem C; Ferdinande R; Lecoq A; Winandy A; Parmentier JC
    Nouv Presse Med; 1974 Mar; 3(12):727-32. PubMed ID: 4836506
    [No Abstract]   [Full Text] [Related]  

  • 4. Toxicity form rifampicin plus isoniazid and rifampicin plus ethambutol therapy.
    Lees AW; Allan GW; Smith J; Tyrrell WF; Fallon RJ
    Tubercle; 1971 Sep; 52(3):182-90. PubMed ID: 4255439
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 6. [The liver and rifampicin].
    Blanchon P; Paillas J; Holler A; Groseille Y; Blanchon B; Blanchon F
    Poumon Coeur; 1973; 29(6):739-52. PubMed ID: 4370583
    [No Abstract]   [Full Text] [Related]  

  • 7. [Determination of adverse reactions of chronic drug therapy as examplified with the hepatotoxic action of isoniazid and rifampicin].
    Bartmann K
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1518-29. PubMed ID: 347784
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug-induced hepatits: the role of unstable metabolites (author's transl)].
    Pessayre D; Benhamou JP
    Acta Gastroenterol Belg; 1978; 41(9-10):574-86. PubMed ID: 735686
    [No Abstract]   [Full Text] [Related]  

  • 9. [Nature of the hepatotoxic action of isoniazid (review of the literature)].
    Skakun NP; Shman'ko VV
    Vrach Delo; 1984 Jan; (1):49-52. PubMed ID: 6367216
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatotoxic effect of a combination of pyrazinamide with isoniazid and rifampicin].
    Slivka IuI; Klimniuk EV; Tabachuk OE
    Probl Tuberk; 1989; (4):39-42. PubMed ID: 2734263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic dysfunction in undernourished patients receiving isoniazid and rifampicin.
    Krishnaswamy K; Prasad CE; Murthy KJ
    Trop Geogr Med; 1991; 43(1-2):156-60. PubMed ID: 1750106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Increase in transaminases and jaundice during treatment with rifampicin combined with isoniazid].
    Kreis B; Boutonnet G
    Rev Tuberc Pneumol (Paris); 1970 Dec; 34(8):1097-106. PubMed ID: 5517156
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synergistic effect of rifampicin on hepatotoxicity of isoniazid].
    Skakun NP; Shman'ko VV
    Antibiot Med Biotekhnol; 1985 Mar; 30(3):185-9. PubMed ID: 4015060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoniazid-rifampicin-induced submassive hepatic necrosis.
    Kasantikul V
    J Med Assoc Thai; 1989 Jan; 72(1):56-8. PubMed ID: 2723568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hydrazide-rifampicin: hepatotoxicity in children].
    Uriz Urzainqui S; Masvidal Aliberch RM; Sabriá Pau J; Bofill Bernaldo AM
    An Esp Pediatr; 1981 Oct; 15(4):401-3. PubMed ID: 7337305
    [No Abstract]   [Full Text] [Related]  

  • 16. Fulminant hepatitis during treatment with rifampicin, pyrazinamid and ethambutol.
    van Aalderen WM; Knoester H; Knol K
    Eur J Pediatr; 1987 May; 146(3):290-1. PubMed ID: 3595648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cholestatic hepatitis during treatment with I.N.H. and rifampicin: arguments in favour of the hepatotoxicity of rifampicin (author's transl)].
    Poupon RY; Meyniel D; Petit J; Gustot P; Darnis F
    Ann Med Interne (Paris); 1979; 130(6-7):371-5. PubMed ID: 496138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Liver damage following antituberculous therapy].
    Thaler H
    Dtsch Med Wochenschr; 1982 Jan; 107(3):113. PubMed ID: 7056159
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatotoxicity of rifampicin and isoniazid in the treatment of tuberculous meningitis (author's transl)].
    Frontera Izquierdo P; Unceta Aguirre L; Tomás Vila M; Calvo Rigual F; Pérez Tamarit D
    An Esp Pediatr; 1981 Dec; 15(6):549-52. PubMed ID: 7337308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the nature of the hepatotoxic action of isoniazid, rifamicin, ethambutol and their combinations against a background of prolonged alcohol administration].
    Ortenberg EA; Zhikhareva AI
    Probl Tuberk; 1980 Feb; (2):59-62. PubMed ID: 7375466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.